🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

Universal Health Services, Inc. UHS SPXR3KPHARMA

Healthcare · Medical Care Facilities · United States
https://uhs.com
Company Profile ↓
$186.89
+5.14% 1Y
Mkt Cap$9.66B
P/E7.63
P/B1.39
Div. Yield0.44%
52W High$243.12
52W Low$141.00
Book Value$127.49
EPS (TTM)$24.49

Company Overview

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 20.9%, reflecting efficient use of shareholder capital.

Healthy Capital Returns

Return on capital employed stands at 16.2%.

Consistent Profit Growth

Net profit has compounded at 12.6% per year over the last five years.

Reasonable Valuation

Trades at a P/E of 7.6, below the sector median of 25.4.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $17.36B (+9.7% YoY); net profit $1.49B.
  • Trailing 12 Months Year-on-year growth — revenue +8.3%, earnings +10.1%.
  • 5-Year Trend Long-term compounding — revenue CAGR 8.8%, profit CAGR 12.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:8.80%
1 Year:8.30%

Compounded Profit Growth

5 Years:12.55%
1 Year:10.10%

Stock Price Performance

1 Year:+5.14%
6 Months:+7.47%
3 Months:+17.45%
1 Month:+5.59%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 45% of range
$141.00 $243.12
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)60.87 · Neutral
Price Performance
1M+5.59%
3M+17.45%
6M+7.47%
1Y+5.14%
Valuation vs Sector

P/E of 7.63 is below the sector median of 25.45 — relatively cheaper than peers.

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 20.9%.
  • Profit CAGR of 12.6% over 5 years.
  • Generates positive free cash flow.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
7.63
Industry PE
25.45
Forward P/E
7.81
PEG Ratio
1.22
Book Value
$127.49
Price to Book
1.39
P/S
0.57
EV/EBITDA
5.81
Dividend Yield
0.44%

Growth (CAGR)

Revenue 5Y
8.80%
Profit 5Y
12.55%
Revenue (YoY)
8.30%
Earnings (YoY)
10.10%

Profitability & Returns

ROCE
16.23%
ROE
20.95%
ROA
8.32%
Profit Margin
8.42%
Op Margin
11.14%
Gross Margin
44.61%
EPS (Latest Qtr)
$5.98
EPS (TTM)
$24.49

Balance Sheet & Liquidity

Debt/Equity
0.69
Quick Ratio
0.89
Current Ratio
1.12
Debt
$5.26B
Total Assets
$15.94B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
4.98%
Chg in Prom Hold
0.15%
FII / Inst Holding
103.41%
Chg in FII Hold
0.14%

Financial Snapshot

Enterprise Value
$9.66B
Total Revenue (TTM)
$18.11B
EBITDA
$2.70B
Free Cash Flow
$498.32M
Operating Cash Flow
$1.80B
Shares Outstanding
51.69M
Gross Margin
44.61%
Payout Ratio
3.27%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 UHS Universal Health Services, Inc. SPXR3KPHARMA 186.89 7.63 $9.66B 0.44% 16.23% 20.95% 8.80% 12.55%
2 LLY Eli Lilly and Company SPXR3KPHARMA 1,273.46 42.83 $1.14T 0.60% - 102.29% 7.20% 11.41%
3 JNJ Johnson & Johnson SPXR3KPHARMA 263.81 30.60 $635.76B 1.98% 14.88% 25.74% 2.43% 4.76%
4 ABBV AbbVie Inc. SPXR3KPHARMA 285.64 80.69 $504.76B 2.54% 10.47% -129.24% 1.75% -29.06%
5 UNH UnitedHealth Group Incorporated SPXR3KPHARMA 418.09 26.85 $375.28B 2.47% 9.74% 14.15% 10.40% 5.43%
6 MRK Merck & Co., Inc. SPXR3KPHARMA 145.27 116.22 $358.41B 2.31% - 6.96% 5.64% 10.01%
7 NVS Novartis AG PHARMA 151.12 22.83 $287.24B 3.36% 21.09% 30.35% 9.25% 26.22%
8 AZN AstraZeneca PLC NDXPHARMA 171.49 25.63 $265.96B 2.00% 15.97% 21.96% 9.82% 45.96%
9 TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA 673.82 36.30 $249.14B 0.29% 8.14% 13.51% 8.81% 12.95%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026Jun 2026
Revenue -------2.61B2.61B2.54B2.64B2.69B2.68B2.65B2.75B2.80B2.86B2.82B2.90B2.83B2.73B2.91B3.09B3.01B3.20B3.16B3.29B3.32B3.34B3.47B3.55B3.56B3.84B3.91B3.96B4.10B4.28B4.50B4.50B4.64B
Operating Income 335.39M275.16M-356.32M333.29M277.57M-353.93M330.19M257.31M-333.81M324.46M257.16M-340.44M345.56M188.93M-236.69M358.03M349.67M-295.67M438.97M314.81M232.86M233.43M275.88M278.70M280.13M285.36M388.76M436.40M384.17M454.82M500.27M521.69M502.86M516.67M
Net Income 182.19M150.29M173.75M190.76M185.58M151.87M174.21M206.06M185.39M141.25M219.61M223.83M226.05M171.75M158.07M234.17M238.32M97.19M245.18M142.04M251.93M241.28M308.71M209.09M325.02M218.35M153.91M164.06M182.81M163.12M171.31M166.99M261.83M289.15M258.71M316.68M353.22M372.96M348.68M358.45M
Diluted EPS 1.801.481.741.931.891.541.782.121.911.472.312.362.391.841.702.572.661.102.791.642.952.823.602.433.792.602.022.202.502.282.422.403.824.263.804.805.435.865.655.98

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue --4.90B6.76B6.96B7.37B8.21B9.04B9.77B10.41B10.77B11.38B11.56B12.64B13.40B14.28B15.83B17.36B
Operating Income 410.22M520.53M505.71M897.13M942.58M1.02B1.06B1.26B1.28B1.28B1.18B1.22B1.36B1.36B1.00B1.18B1.68B1.99B
Net Income 199.38M260.37M230.18M398.17M443.45M510.73M545.34M680.53M702.41M752.30M779.71M814.85M943.95M991.59M675.61M717.79M1.14B1.49B
Diluted EPS 1.962.642.344.044.535.145.426.767.147.818.319.1310.9911.829.1410.2316.8223.10

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --3.96B7.53B7.67B8.20B8.31B8.95B9.62B10.32B10.76B11.27B11.67B13.48B13.09B13.49B13.97B14.47B15.53B
Total Equity 1.55B1.58B1.75B1.98B2.30B2.71B3.25B3.74B4.25B4.53B4.99B5.39B5.50B6.32B6.09B5.92B6.15B6.67B7.28B
Cash & Equivalents 16.35M5.46M9.18M29.47M41.23M23.47M17.24M32.07M61.23M33.75M74.42M105.22M61.27M1.22B115.30M102.82M119.44M125.98M137.80M
Long Term Debt --956.43M3.91B3.65B3.73B3.21B3.21B3.37B4.03B3.49B3.94B3.90B3.52B4.14B4.73B4.79B4.46B4.00B
Current Liabilities --582.82M826.30M836.93M894.06M1.06B1.18B1.10B1.32B1.85B1.45B1.56B2.48B1.98B1.91B2.01B2.21B3.24B

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 494.19M541.26M501.34M710.68M799.23M884.24M1.04B1.07B1.33B1.25B1.27B1.44B2.36B883.70M996.02M1.27B2.07B1.86B
Investing Cash Flow -295.67M-390.43M-2.19B-285.81M-789.59M-383.46M-832.85M-912.88M-1.16B-684.73M-747.25M-688.41M-802.56M-914.47M-647.30M-763.27M-911.11M-1.07B
Financing Cash Flow -209.41M-147.11M1.71B-413.12M-27.40M-507.02M-187.42M-124.61M-171.17M-519.15M-492.20M-845.04M-384.86M-1.07B-318.40M-493.94M-1.14B-749.73M
Capital Expenditure -354.54M-379.75M-239.27M-285.68M-363.19M-358.49M-391.15M-379.32M-519.94M-557.51M-664.96M-634.10M-731.31M-855.66M-734.00M-743.05M-943.81M-1.02B
Free Cash Flow 139.65M161.51M262.07M425.00M436.04M525.75M644.73M688.94M813.90M690.08M609.78M804.37M1.63B28.04M262.02M524.74M1.12B849.25M
Share Buybacks 149.40M63.29M11.53M60.48M19.15M27.20M100.75M209.78M353.38M364.40M397.43M770.50M206.72M1.22B832.92M547.36M670.75M967.95M
Dividends Paid 16.15M16.71M19.42M19.47M58.40M19.62M29.66M39.53M38.88M38.21M37.34M-------

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ------------------
Operating Margin % --10.3%13.3%13.5%13.8%13.0%13.9%13.1%12.3%10.9%10.7%11.8%10.8%7.5%8.2%10.6%11.5%
Net Margin % --4.7%5.9%6.4%6.9%6.6%7.5%7.2%7.2%7.2%7.2%8.2%7.8%5.0%5.0%7.2%8.6%
ROE % 12.6%14.9%11.6%17.3%16.3%15.7%14.6%16.0%15.5%15.1%14.5%14.8%14.9%16.3%11.4%11.7%17.1%20.5%
ROCE % -15.4%7.5%13.1%12.9%14.0%13.7%14.8%14.2%14.4%12.0%12.0%12.4%12.3%8.7%9.8%13.7%16.2%

Shareholding Pattern

Insiders
4.98%
Institutions
103.41%
Public Float
108.82%

Top Institutional Holders

#Holder% HeldSharesValue
1 First Eagle Investment Management, LLC 8.81% 4.55M $807.77M
2 Blackrock Inc. 7.85% 4.06M $720.01M
3 Vanguard Capital Management LLC 6.56% 3.39M $601.61M
4 Vanguard Portfolio Management LLC 4.74% 2.45M $434.89M
5 Dimensional Fund Advisors LP 4.28% 2.21M $392.05M
6 State Street Corporation 4.07% 2.10M $372.90M
7 Geode Capital Management, LLC 3.82% 1.97M $350.10M
8 Pzena Investment Management LLC 3.81% 1.97M $349.26M
9 Invesco Ltd. 3.77% 1.95M $346.04M
10 FMR, LLC 2.74% 1.42M $251.26M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for UHS

Google News Fri, 23 Oct 2026

Universal Health Services, Inc. (UHS) Stock forecasts - Yahoo Finance UK

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxOWUx4SWpKSjdIeW5IRUlTS1RXdnhaLVR5cEd2OU50Ylc1aGlTeUxfYnViRFNabmpoV0dmOS10czFxXzBZZk5JbGg2N2xGMi1oMHd0OHRxbmNBRkpPck9rWno2MGdkSTZkbkVvRTExall0MlV6RUNWbndHaW11Yk4wUnJWOVpUVUk1NU5teW…

Google News Fri, 23 Oct 2026

Universal Health Services, Inc. Class B Estimates – SWB:UHS - TradingView

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE9IZFBndVNfVnc4Tmw0OFlXejlqN1VhZzh1TjhXdGRPeU9NX1d5U09BczNrX1VYSlJ5eGN4QVJXczd6OU9PRTEwUW9IUUpWTUM2ZDZva1dvZzgxMk1Jd0dMOThaWlpoYTExWE1XUnVqQ3hpN3c?oc=5" target="_blank">Universal He…

Google News ue, 20 Oct 2026

Universal Health: Bears Have Taken It Too Far - 134% Upside (NYSE:UHS) - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNaE03cmdiZGpzNXlKTmZUb2RranZpczY2YzhsX0dpNkJvX2R5azFMNlpiUnRxT2VwWU1nYUhpdWdHbXVjTm5nN3JHbHViMWVUaWNkR1RLdTB6c2kxeFRFd2NxZEh0ckM4TE1pU3ZtNGxvbjlJc3JRVTFpbktYZlMya01FeWtjTXhNTjBBX0…

Google News Wed, 21 Oct 2026

Universal Health Services Inc. Cl B stock underperforms Wednesday when compared to competitors - MarketWatch

<a href="https://news.google.com/rss/articles/CBMigAJBVV95cUxOS1Q3cVA5NkZNME5qYkNXMG5KcUU5ZlY5LWp2ZGhiOUlHNEE4SGd1alp5OU01OG00WWdUWGttOGZNcjA0Si1vRVdlRzRhcXNzaHhNdm5pYmFlZG5Ld2E4YlkxSEdnVVFvZWNKVEMzS2JGb01CRUtDTVcxZWNZQkhWX1l0X3dVeHVqcXN2Nm…

Google News hu, 22 Oct 2026

Universal Health Services, Inc. (UHS) Stock Forecasts - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxNZGpOaE83ck9pQXo5czZNcnJOMzlOdUJ5MWNQODRlUlRMTDY3TE1rTmI3eFU4Mjc0WjZMLXF2eVZyWGRPR3lVbTBsMXkyamR4RkVWRHNSZWlHQTVnUVRRZXZFOUZQRUE5OC1KUnF0TS14UXhLNDNKY1QwakNpbzhTTUg1QlJSUVMycDZyWm…

Google News Wed, 21 Oct 2026

Can Higher Admissions Offset Rising Costs in UHS' Q3 Earnings? - TradingView

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNaHZRU1lpSDRNUWNFRW9pcm9XUE5NZU41T0NkamdvUnowQlFuUV9rRkRDdENxR0FlOFlvVVlFNzVlV0czZVlHY3pUX0FBZ1R3TGNzb2F2aDVmcURMMENxZTk0Vkc4VFFfUElOLS1rb0dia1A2VUNSNVlLNW9NYlF0MmI3bnV5Q0piTW5iYV…

UHS — Frequently Asked Questions

What is the current share price of Universal Health Services, Inc. (UHS)?

As of 2026-10-23 16:27 PDT, Universal Health Services, Inc. (UHS) trades at $186.89 on NYSE. Its 52-week range is $141.00 to $243.12.

What is the market capitalisation of UHS?

Universal Health Services, Inc. (UHS) has a market capitalisation of $9.66B on NYSE.

What is the P/E ratio of UHS?

UHS trades at a trailing price-to-earnings (P/E) ratio of 7.63. The industry average P/E is 25.45. Its price-to-book (P/B) ratio is 1.39.

Does UHS pay a dividend?

Universal Health Services, Inc. (UHS) currently offers a dividend yield of 0.44%.

What is the return on equity (ROE) of UHS?

UHS has a return on equity (ROE) of 20.95%. Its return on capital employed (ROCE) is 16.23%.

Is UHS a good stock to buy?

This page provides a data-driven analysis of Universal Health Services, Inc. (UHS), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space